nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Foetor hepaticus—Progesterone—uterine cancer	0.0501	0.0501	CcSEcCtD
Capreomycin—Foetor hepaticus—Medroxyprogesterone Acetate—uterine cancer	0.0454	0.0454	CcSEcCtD
Capreomycin—Liver disorder—Progesterone—uterine cancer	0.0417	0.0417	CcSEcCtD
Capreomycin—Liver disorder—Medroxyprogesterone Acetate—uterine cancer	0.0378	0.0378	CcSEcCtD
Capreomycin—Abscess—Progesterone—uterine cancer	0.0359	0.0359	CcSEcCtD
Capreomycin—Abscess—Medroxyprogesterone Acetate—uterine cancer	0.0325	0.0325	CcSEcCtD
Capreomycin—Induration—Etoposide—uterine cancer	0.0325	0.0325	CcSEcCtD
Capreomycin—Hypocalcaemia—Progesterone—uterine cancer	0.031	0.031	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—uterine cancer	0.0302	0.0302	CcSEcCtD
Capreomycin—Hepatocellular injury—Progesterone—uterine cancer	0.0284	0.0284	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—uterine cancer	0.028	0.028	CcSEcCtD
Capreomycin—Leukocytosis—Medroxyprogesterone Acetate—uterine cancer	0.0274	0.0274	CcSEcCtD
Capreomycin—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.0257	0.0257	CcSEcCtD
Capreomycin—Nephropathy toxic—Etoposide—uterine cancer	0.0253	0.0253	CcSEcCtD
Capreomycin—Hypocalcaemia—Dactinomycin—uterine cancer	0.0219	0.0219	CcSEcCtD
Capreomycin—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.017	0.017	CcSEcCtD
Capreomycin—Pain—Carboplatin—uterine cancer	0.0165	0.0165	CcSEcCtD
Capreomycin—Body temperature increased—Carboplatin—uterine cancer	0.0153	0.0153	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—uterine cancer	0.0147	0.0147	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—uterine cancer	0.0139	0.0139	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—uterine cancer	0.0136	0.0136	CcSEcCtD
Capreomycin—Tinnitus—Progesterone—uterine cancer	0.0133	0.0133	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—uterine cancer	0.0128	0.0128	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—uterine cancer	0.0128	0.0128	CcSEcCtD
Capreomycin—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.0121	0.0121	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—uterine cancer	0.0119	0.0119	CcSEcCtD
Capreomycin—Vertigo—Progesterone—uterine cancer	0.0112	0.0112	CcSEcCtD
Capreomycin—Abscess—Epirubicin—uterine cancer	0.0103	0.0103	CcSEcCtD
Capreomycin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0101	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—uterine cancer	0.00953	0.00953	CcSEcCtD
Capreomycin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00899	0.00899	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—uterine cancer	0.0089	0.0089	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—uterine cancer	0.00884	0.00884	CcSEcCtD
Capreomycin—Pain—Progesterone—uterine cancer	0.00867	0.00867	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—uterine cancer	0.00823	0.00823	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—uterine cancer	0.00818	0.00818	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—uterine cancer	0.00815	0.00815	CcSEcCtD
Capreomycin—Urticaria—Progesterone—uterine cancer	0.00805	0.00805	CcSEcCtD
Capreomycin—Body temperature increased—Progesterone—uterine cancer	0.00801	0.00801	CcSEcCtD
Capreomycin—Renal failure—Etoposide—uterine cancer	0.00799	0.00799	CcSEcCtD
Capreomycin—Leukopenia—Dactinomycin—uterine cancer	0.00786	0.00786	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—uterine cancer	0.00754	0.00754	CcSEcCtD
Capreomycin—Hypersensitivity—Progesterone—uterine cancer	0.00747	0.00747	CcSEcCtD
Capreomycin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.0073	0.0073	CcSEcCtD
Capreomycin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00726	0.00726	CcSEcCtD
Capreomycin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00701	0.00701	CcSEcCtD
Capreomycin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00677	0.00677	CcSEcCtD
Capreomycin—Rash—Progesterone—uterine cancer	0.00639	0.00639	CcSEcCtD
Capreomycin—Dermatitis—Progesterone—uterine cancer	0.00638	0.00638	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—uterine cancer	0.00621	0.00621	CcSEcCtD
Capreomycin—Pain—Dactinomycin—uterine cancer	0.00613	0.00613	CcSEcCtD
Capreomycin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00579	0.00579	CcSEcCtD
Capreomycin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00579	0.00579	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—uterine cancer	0.00575	0.00575	CcSEcCtD
Capreomycin—Vertigo—Etoposide—uterine cancer	0.00571	0.00571	CcSEcCtD
Capreomycin—Leukopenia—Etoposide—uterine cancer	0.00569	0.00569	CcSEcCtD
Capreomycin—Body temperature increased—Dactinomycin—uterine cancer	0.00566	0.00566	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—uterine cancer	0.00538	0.00538	CcSEcCtD
Capreomycin—Hypersensitivity—Dactinomycin—uterine cancer	0.00528	0.00528	CcSEcCtD
Capreomycin—Thrombocytopenia—Etoposide—uterine cancer	0.00508	0.00508	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—uterine cancer	0.00506	0.00506	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—uterine cancer	0.00498	0.00498	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—uterine cancer	0.00468	0.00468	CcSEcCtD
Capreomycin—Rash—Dactinomycin—uterine cancer	0.00452	0.00452	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—uterine cancer	0.00448	0.00448	CcSEcCtD
Capreomycin—Pain—Etoposide—uterine cancer	0.00443	0.00443	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—uterine cancer	0.00414	0.00414	CcSEcCtD
Capreomycin—Urticaria—Etoposide—uterine cancer	0.00412	0.00412	CcSEcCtD
Capreomycin—Body temperature increased—Etoposide—uterine cancer	0.0041	0.0041	CcSEcCtD
Capreomycin—Hypersensitivity—Etoposide—uterine cancer	0.00382	0.00382	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—uterine cancer	0.00381	0.00381	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—uterine cancer	0.00353	0.00353	CcSEcCtD
Capreomycin—Rash—Etoposide—uterine cancer	0.00327	0.00327	CcSEcCtD
Capreomycin—Dermatitis—Etoposide—uterine cancer	0.00327	0.00327	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—uterine cancer	0.0032	0.0032	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—uterine cancer	0.00319	0.00319	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—uterine cancer	0.00296	0.00296	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—uterine cancer	0.00295	0.00295	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—uterine cancer	0.00285	0.00285	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—uterine cancer	0.00263	0.00263	CcSEcCtD
Capreomycin—Pain—Epirubicin—uterine cancer	0.00249	0.00249	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Capreomycin—Pain—Doxorubicin—uterine cancer	0.0023	0.0023	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—uterine cancer	0.0023	0.0023	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—uterine cancer	0.00213	0.00213	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Capreomycin—Rash—Epirubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Capreomycin—Rash—Doxorubicin—uterine cancer	0.0017	0.0017	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
